(Q46735690)

24 December 2017

title

Effect of albumin on transplacental transfer and distribution of rosiglitazone and glyburide (English)

1 reference

24 December 2017

1 reference

5

1 reference

24 December 2017

Gary D. V. Hankins

6

object named as

Gary D Hankins

1 reference

24 December 2017

author name string

Tatiana N Nanovskaya

1

1 reference

24 December 2017

Svetlana Patrikeeva

2

1 reference

24 December 2017

Sarah Hemauer

3

1 reference

24 December 2017

Valentina Fokina

4

1 reference

24 December 2017

Mahmoud S Ahmed

7

1 reference

24 December 2017

OPRU Network

8

1 reference

24 December 2017

publication date

1 March 2008

1 reference

24 December 2017

Journal of Maternal-Fetal and Neonatal Medicine

published in

1 reference

24 December 2017

volume

21

1 reference

24 December 2017

issue

3

1 reference

24 December 2017

page(s)

197-207

1 reference

24 December 2017

Insignificant transfer of glyburide occurs across the human placenta.

cites work

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Effects of rosiglitazone in obese women with polycystic ovary syndrome and severe insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Endocrine and metabolic effects of rosiglitazone in overweight women with PCOS: a randomized placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Effect of rosiglitazone on insulin resistance, growth factors, and reproductive disturbances in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

A case of rosiglitazone exposure in the second trimester of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Placental transfer of rosiglitazone in the first trimester of human pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Transplacental transfer and metabolism of buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Simple method for the determination of rosiglitazone in human plasma using a commercially available internal standard

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Oral hypoglycemic agents and the pregnant diabetic: "from bench to bedside".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Liquid chromatographic method for the determination of rosiglitazone in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

Transport of glyburide by placental ABC transporters: implications in fetal drug exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F14767050801929901

10.1080/14767050801929901

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

PubMed ID

18297575

1 reference

24 December 2017